
Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Ajax Engineering Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
36 crores in FY '22 to Rs. Key concall takeaways from Ajax Engineering's Q4 FY25 earnings call — and how it ranks against sector peers.
6 Aug 2026
Dr Agarwals Health Care Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Same-store sales growth is strong, exceeding 13.5%, reflecting healthy organic growth. Key concall takeaways from Dr Agarwals Health Care Ltd's Q3 FY26…
6 Aug 2026
Dr Agarwals Health Care Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Southern region remains the largest market, showing strong growth (22.2% YoY), with plans to add 17 new facilities in the next two quarters, reinforcing…
6 Aug 2026
Dr Agarwals Health Care Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Mature facilities have exhibited strong growth with a same-store sales CAGR of about 18% from FY '22 to FY '24. Key concall takeaways from Dr Agarwals Health…
6 Aug 2026
OneSource Specialty Pharma Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Q2 FY26 showed strong revenue growth and a 37% rise in EBITDA with a 500+ bps margin expansion. Key concall takeaways from OneSource Specialty Pharma Ltd's Q2…
6 Aug 2026
OneSource Specialty Pharma Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
The company has significantly reduced high-cost debt, cutting it by almost 50% by the end of the last quarter (net of cash and cash equivalents). Key concall…
6 Aug 2026
OneSource Specialty Pharma Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Return on capital employed (ROCE) is in the mid-30% range and trending positively. Key concall takeaways from OneSource Specialty Pharma Ltd's Q3 FY25 earnings…
6 Aug 2026
EMA Partners India Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
1 crore annually. Key concall takeaways from EMA Partners India Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
6 Aug 2026
Rossell Techsys Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Rossell Techsys has demonstrated extraordinary growth, delivering in two financial years the revenue it took 14 years to achieve earlier (~INR1,300 crores)…
6 Aug 2026
Fabtech Technologies Cleanrooms Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Current consolidated order book (Fabtech + Kelvin) stands at around INR 90 crores. Key concall takeaways from Fabtech Technologies Cleanrooms's Q4 FY25 earnings call — and how…
6 Aug 2026
Nacdac Infrastructure Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Current order book stands at approximately INR118 crores as of FY 2025. Key concall takeaways from Nacdac Infrastructure Ltd's Q4 FY25 earnings call — and how…
6 Aug 2026
International Gemological Institute Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Volume growth for the year aligns with the revenue growth, with volumes having grown 24% in the first half of 2025. Key concall takeaways from International…
6 Aug 2026
International Gemological Institute Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
The company is experiencing rapid volume growth, with 26% growth at the group level and 22% at the India level in Q1. Key concall takeaways from International…
6 Aug 2026
International Gemological Institute Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Certification demand growth is consistent, with LGD certifications growing from 20% to over 30% of mix, contributing to volume increases. Key concall takeaways…
6 Aug 2026
Standard Engineering Technology Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Significant capacity expansion with a new 36-acre facility adding potential INR 2,000 crores capacity in addition to existing INR 2,000 crores. Key concall…
6 Aug 2026
Standard Engineering Technology Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Incremental revenue potential up to INR 3,000 crores following planned capex investments of INR 130-200 crores. Key concall takeaways from Standard Engineering…
6 Aug 2026
Standard Engineering Technology Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
During the IPO, order book was around INR 400 crores, and the management confirms good order inflows since then, though specific numbers are not shared. Key…
6 Aug 2026
Unimech Aerospace and Manufacturing Q2 FY26: Order Book ₹105 Cr | Arthneeti
Q2 FY26
1,000 crores in revenue by FY29, with approximately 65% from aero tooling and 35% from nuclear and precision segments. Key concall takeaways from Unimech…
6 Aug 2026
Unimech Aerospace and Manufacturing Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Current order book stands close to INR 93-100 crores, holding good for approximately 3 to 4 months of revenue. Key concall takeaways from Unimech Aerospace and…
6 Aug 2026
Carraro India Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Capacity expansion underway with INR 60-63 crore capex over 12-18 months to support 20,000 additional axle capacity. Key concall takeaways from Carraro India…
6 Aug 2026
Arthneeti Pro · Annual
Every earnings call this season,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access